Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × hCG × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8936 Neoplasms 6862 Carcinoma, Non-Small-Cell Lung 5022 Prostatic Neoplasms 4434 Colorectal Neoplasms 4016 Lung Neoplasms 3251 Leukemia, Myeloid, Acute 2709 Neoplasm Metastasis 2702 Multiple Myeloma 2690 Pancreatic Neoplasms 2507 Melanoma 2333 Lymphoma 2276 Ovarian Neoplasms 2259 Carcinoma, Hepatocellular 2170 Stomach Neoplasms 2053 Recurrence 1945 Head and Neck Neoplasms 1832 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1819 Lymphoma, Non-Hodgkin 1805 Leukemia 1792 Brain Neoplasms 1703 Glioblastoma 1596 Colonic Neoplasms 1566 Leukemia, Lymphocytic, Chronic, B-Cell 1542 Rectal Neoplasms 1508 Uterine Cervical Neoplasms 1456 Lymphoma, Follicular 1428 Squamous Cell Carcinoma of Head and Neck 1427 Lymphoma, Large B-Cell, Diffuse 1394 Carcinoma, Renal Cell 1371

Interventions

Chorionic Gonadotropin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03495609 2023-09-07

Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers

University Hospital, Ghent

Phase 4 Completed

hCG

Data powered by HemOnc (CC BY 4.0) Colophon ⚡